Dibutyltin dichloride (683-18-1)
Study Data
Other NTP Studies
ADME/TK Evaluation (S0875) of Dibutyltin Dichloride (683-18-1) in F344 Rats and B6C3F1 Mice Exposed via Gavage or Intravenous Injection
Summary and Individual Data – Toxicokinetics
Summary Data - Male Rats
- Gavage Multiple Dose 10X (0.1 mg/kg, Study Duration 70 days post last dose) (57 kB)
- Gavage Multiple Dose 10X (0.1 mg/kg, Study Duration to 14 days) (33 kB)
- Gavage Multiple Dose 5X (0.1 mg/kg, Study Duration 3 days post last dose) (40 kB)
- Gavage Multiple Dose 5X and 10X (0.1 mg/kg, Study Duration 3 or 18 days post last dose) (32 kB)
- Gavage Single Dose (0.09 mg/kg, Study Duration 72 hours) Tissue (40 kB)
- Gavage Single Dose (0.09, 1.1, or 11 mg/kg, Study Duration 72 hours) Excreta & Summary (38 kB)
- Gavage Single Dose (0.1 mg/kg, Study Duration 8 hours) Summary (26 kB)
- Gavage Single Dose (0.1 mg/kg, Study Duration 8 hours) Tissue (39 kB)
- Gavage Single Dose (0.10 mg/kg, Excreta with Bile, Study Duration 24 hours) Summary (37 kB)
- Gavage Single Dose (0.10 mg/kg, Excreta with Bile, Study Duration 24 hours) Tissue (39 kB)
- Gavage Single Dose (1.1 mg/kg, Study Duration 72 hours) Tissue (41 kB)
- Gavage Single Dose (10.0 mg/kg, Study Duration 8 hours) Summary (37 kB)
- Gavage Single Dose (10.0 mg/kg, Study Duration 8 hours) Tissue (40 kB)
- Gavage Single Dose (11 mg/kg, Study Duration 72 hours) Tissue (40 kB)
- Gavage Single Dose (12.0 mg/kg, Excreta with Bile, Study Duration 8 hours) (37 kB)
- Gavage Single Dose (13.0 mg/kg, Helicobacter Infected, Study Duration 8 hours) Summary (37 kB)
- Gavage Single Dose (13.0 mg/kg, Helicobacter Infected, Study Duration 8 hours) Tissue (43 kB)
- IV Single Dose (0.11 mg/kg, Excreta with Bile, Study Duration 24 hours) Summary (39 kB)
- IV Single Dose (0.11 mg/kg, Excreta with Bile, Study Duration 24 hours) Tissue (39 kB)